Membranous Nephropathy clinical trials at UCSF

1 in progress, 0 open to eligible people

Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy
Sorry, not currently recruiting here
This study is a Phase 1b/2a, open-label, sequential-cohort, dose escalation, and dose expansion study to evaluate the safety, tolerability, PK, and PD of VB119 in subjects with primary MN
San Francisco, California and other locations

Last updated: July 19, 2022